SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-006083
Filing Date
2023-08-25
Accepted
2023-08-25 16:42:37
Documents
14
Period of Report
2023-08-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 36021
2 PRESS RELEASE acon_ex9901.htm EX-99.1 5971
  Complete submission text file 0001683168-23-006083.txt   264388

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE acon-20230823.xsd EX-101.SCH 3788
4 XBRL DEFINITION FILE acon-20230823_def.xml EX-101.DEF 26648
5 XBRL LABEL FILE acon-20230823_lab.xml EX-101.LAB 36765
6 XBRL PRESENTATION FILE acon-20230823_pre.xml EX-101.PRE 25272
8 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5290
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 231208974
SIC: 8071 Services-Medical Laboratories